SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David S. who wrote (900)7/9/1997 2:47:00 PM
From: JOHN W.   of 6136
 
David, thank you for your post. Could you answer the following questions:
1) Why has MRK conducted such an aggressive AD campaign in "Mens Health", "GQ", etc If Crixivan is such a good alternative to Viracept. Could it be the drastic maket share loss that Crix is undergoing since Viracept approval ?
2) I thought all of the PI(s) prevented the replication of the virus. What do they do then?
3) Is it not possible that the 7 analyst who reccomend AGPH to their clients as STRONG BUYs are trying to increase their wealth in a highly promising company? How does an analyst lie about a company's prospects to "win corporate finance business"? Are all 7 guilty of this?
4) What scientific evidence do you have to reference that 39% of patients receive no benefit from Viracept. "Respond" means a decrease in viral load.
5) How does the ad violate the FDA guidelines?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News